Guanylate-binding proteins (GBPs) are a group interferon-inducible GTPases within the constellation of the dynamin GTPase superfamily. These proteins restrict the replication of intracellular pathogens in both immune and non-immune cells. GBPs and their related family members immunity-related GTPases target and lyse the membrane of the pathogen-containing vacuole, destroying the residential niche of vacuolar protozoal and bacterial pathogens. They also prevent virion infectivity and target replication complexes of ribonucleic acid viruses. The exciting concept that GBPs and immunity-related GTPases can directly target the membrane of bacteria and protozoa has emerged. Rupture and lysis of the pathogen membrane mediates liberation of concealed microbial ligands for activation of innate immune sensing pathways and the inflammasome. Further studies have demonstrated a capacity of GBPs to recruit additional antimicrobial factors, highlighting the complexity of the molecular mechanisms involved in pathogen killing. In this mini-review, we discuss recent advances describing the localisation and functions of GBPs on the host and pathogen membrane. We also highlight unresolved questions related to the regulation of GBPs in cell-autonomous immunity to intracellular pathogens. GTPases that have central roles in cell-autonomous immunity (Kim et al., 2016; Man, Place, Kuriakose, & Kanneganti, 2017; Meunier & Broz, 2016; Pilla-Moffett, Barber, Taylor, & Coers, 2016) . GBPs belong to the dynamin GTPase superfamily whose expression are induced by type I IFN members IFN-α subtypes and IFN-β, and the type II IFN member IFN-γ (Cheng, Colonno, & Yin, 1983; Platanias, 2005; Praefcke & McMahon, 2004; Tripal et al., 2007) . Other members of the dynamin GTPase superfamily include the immunity-related GTPases (IRGs), myxoma resistance proteins, and the very large inducible GTPases (MacMicking, 2004; Martens & Howard, 2006; Figure 1 ).
the protein (Ghosh et al., 2006; Vopel et al., 2014; Vopel, Kunzelmann, & Herrmann, 2009) . Similarly, other GBPs and members of the dynamin GTPase superfamily are able to undergo homodimerisation and/or heterodimerisation with one another (Faelber et al., 2013; Praefcke & McMahon, 2004) .
Post-translation modifications contribute to the functional roles of
GBPs. GBP2 and GBP5 undergo isoprenylation (Britzen-Laurent et al., 2010; Wang & Casey, 2016) , a form of covalent attachment of a lipid hydrophobic moiety 15-carbon farnesyl or 20-carbon geranylgeranyl group to a cysteine residue of a C-terminal CaaX motif. In this CaaX motif, "C" refers to cysteine, "a" for aliphatic amino acid, and "X"
indicates any amino acids. The X amino acid residue determines the identity of the lipid added to the protein (Choy et al., 1999) . GBP1 is poorly isoprenylated despite carrying a CaaX motif (Stickney & Buss, 2000) . Isoprenylation promotes the ability of GBPs to associate with membranes and with one another (Britzen-Laurent et al., 2010; Choy et al., 1999) . Although this post-translational modification is not absolutely essential for mediating interaction with membranes, isoprenylated GBPs have an increased capacity to target certain pathogen-associated membrane compared to those not isoprenylated These pathogens include the Gram-negative bacterium Francisella novicida, the Gram-positive bacterium Listeria monocytogenes, and many viruses. GBPs exert antimicrobial mechanisms against pathogens with diverse intracellular lifestyles. In this mini-review, we discuss the molecular mechanisms regulating membrane association and rupture by GBPs and related family members, focusing on the antimicrobial activity of these proteins in the context of infectious diseases.
| Functions on the host membrane and the pathogen-containing vacuole
GBPs have the capacity to recruit to both host membrane and membrane of the pathogen-containing vacuole. Earlier studies have 
Phylogenetic tree of human (h) and mouse (m) interferon-inducible GTPases based on protein sequences and drawn by MEGA software version 7. Scale bar, substitutions per site shown that human GBP1 can localise to the Golgi apparatus in the presence of aluminium fluoride, a chemical that binds GDP-bound proteins to generate a GTP hydrolysis transition state (Modiano, Lu, & Cresswell, 2005) . Human GBP1 undergoes farnesylation, a type of isoprenylation involving addition of an isoprenoid lipid to the cysteine residue at the C-terminal region of the protein (Vestal & Jeyaratnam, 2011) . Introduction of a mutation to human GBP1 that impairs its ability to undergo farnesylation (residue C589S) or bind GTP (residue R48P) has an inhibitory effect on the migration of GBP1 to the Golgi apparatus (Modiano et al., 2005) . Indeed, the CaaX motif of GBP1, GBP2, and GBP5 is required to direct their localisation to the Golgi apparatus (Britzen-Laurent et al., 2010) . Furthermore, farnesylated human GBP1 binds liposomes in the presence of the compound GDP * AlFx that serves as a mimic of the transition state of GTPase hydrolysis (Fres, Muller, & Praefcke, 2010) . More recent biochemical analyses revealed that farnesylated human GBP1 can either polymerise into higher ordered structures or attach to membranes and cause membrane tethering (Shydlovskyi et al., 2017) . Although the precise biological importance of localisation of GBPs to host-derived membrane is still unclear, these studies imply that the putative functions may relate to regulation of membrane dynamics and/or intracellular trafficking.
GBPs can also target the membrane of the pathogen-containing vacuole ( Figure 2b ). GBPs are recruited to the pathogen-containing vacuole encasing the protozoan parasite T. gondii (also known as the parasitophorous vacuole) in primary bone-marrow-derived macrophages (BMDMs) and murine embryonic fibroblasts (MEFs; Degrandi et al., 2013; Kravets et al., 2016; Selleck et al., 2013; Yamamoto et al., 2012) . Microscopy analysis revealed potential interactions between GBP1, GBP2, GBP3, GBP5, and GBP6 on the pathogen-containing vacuole, resulting in the formation of large supramolecular complexes composed of thousands of monomeric GBPs (Kravets et al., 2016; Selleck et al., 2013) . Redistribution of cytoplasmic GBPs to the pathogen-containing vacuole is rapid and can be observed within 10 min of infection Rupture of the pathogen membrane leads to liberation of bacterial DNA that is sensed by the DNA-sensing AIM2 inflammasome. GBPs also migrate to the pathogen-containing vacuole surrounding vacuolar bacteria including Salmonella enterica serovar Typhimurium. Rupture of the vacuole leads to the release of lipopolysaccharides that activates caspase-11 and the non-canonical NLRP3 inflammasome. GBPs also deliver nicotinamide adenine dinucleotide phosphate oxidase and/or lysosomes to the pathogen-containing vacuole to mediate killing of bacteria. (d) GBP5 associated with the Golgi apparatus can interfere with the infectivity of the RNA human immunodeficiency virus and simian immunodeficiency virus. GBPs and IRGs are further recruited to the replication complex induced by the RNA virus norovirus to curtail viral replication. GBP1 disrupts the formation of actin filaments and inhibits the delivery of the DNA virus Kaposi's sarcoma-associated herpesvirus to the host nucleus T. gondii fails to undergo destabilisation in BMDMs lacking GBP chr3 (Yamamoto et al., 2012) . Another study reported that MEFs lacking GBP2 have substantially fewer disrupted vacuoles after 5 and 8 hr of
T. gondii infection compared to that in wild-type MEFs . Restriction of T. gondii replication in MEFs requires the ability of GBP2 to undergo nucleotide binding, GTP hydrolysis, isoprenylation, or oligomerisation (Kravets et al., 2016; Ohshima et al., 2015) . Nucleotide binding and isoprenylation of GBP2 further promote the recruitment of the IRG member IRGA6 to the pathogen-containing vacuole to restrict T. gondii replication (Ohshima et al., 2015) . Recruitment of GBP1, GBP2, GBP3, GBP4, GBP5, and IRGA6 to the pathogen-containing vacuole of MEFs infected with T. gondii is further guided by the E2 conjugating enzyme ATG3 and gamma-aminobutyric acid receptor-associated protein autophagy proteins (Sasai et al., 2017) .
A more recent study found that human GBP1, which is strongly expressed in mesenchymal stromal cells infected with T. gondii, localises to the pathogen-containing vacuole (Qin et al., 2017) . Genetic knockdown of the gene encoding human GBP1, but not GBP2 and GBP5, in mesenchymal stromal cells leads to an accelerated intracellular growth of T. gondii (Qin et al., 2017) , suggesting a crucial role for GBP1 in inhibiting protozoal replication in this cell type. In contrast,
another study suggested that in A549 lung epithelial cells, human GBP1 does not associate with the pathogen-containing vacuole carrying either T. gondii or the bacterial pathogens Chlamydia trachomatis or S. Typhimurium (Johnston et al., 2016) . These studies clearly highlight that the relative contribution of each GBP in the host defence against a pathogen is cell-type-specific.
Recruitment of GBPs to the pathogen-containing vacuole may eventually leads to lysis of the vacuolar membrane Kravets et al., 2016; Yamamoto et al., 2012) . Following rupture of the pathogen-containing vacuole, the parasite membrane is targeted by GBP2, which mediates killing of the invading protozoan (Kravets et al., 2016 ; discussed further below). Similar to GBPs, loading of multiple IRGs onto the pathogen-containing vacuole carrying T. gondii has been observed. In this case, the recruitment of IRGs is sequential and highly orchestrated, starting with the recruitment of IRGA6, followed by IRGB6, IRGD, and IRGM2 (Khaminets et al., 2010) . vacuole, galectin-8, compared to that in wild-type BMDMs (Meunier et al., 2014) . These observations indicate that GBP chr3 promote lysis of the pathogen-containing vacuoles and liberation of the bacteria into the cytoplasm (Figure 2c ).
The release of bacteria into the sterile environment of the host cytoplasm has important biological consequences. The current view is that GBP chr3 -mediated release of Gram-negative bacteria results in contamination of the cytoplasm with lipopolysaccharide (LPS), which causes robust activation of the LPS sensor caspase-11 (Meunier et al., 2014) . Caspase-11 then triggers pyroptosis and activation of the NLRP3 inflammasome, an innate immune signalling complex that mediates secretion of the pro-inflammatory cytokines IL-1β and IL-18 Mathur, Hayward, & Man, 2017) .
Furthermore, GBP chr3 are required for caspase-11-induced pyroptosis in IFN-γ-treated BMDMs in response to cytosolic delivery of LPS derived from the Gram-negative bacterium Legionella pneumophila (Pilla et al., 2014) , suggesting that GBP chr3 may also facilitate translocation of free LPS into the cytoplasm or promote oligomerisation and activation of caspase-11. Cytosolic pathogens capable of escaping the pathogencontaining vacuole into the cytoplasm, such as the Gram-negative bacterium Burkholderia thailandensis, can trigger activation of caspase-11 in a manner independent of GBP chr3 (Aachoui et al., 2013; Meunier et al., 2014) .
It is likely that rupture of the pathogen-containing vacuole represents only one of many mechanisms by which GBPs contribute to activation of the inflammasome. In some scenarios, recruitment of GBPs to the pathogen-containing vacuole is not essential for activation of the inflammasome. Unlike in the case of most Gram-negative bacteria, GBP chr3 potentiate activation of the inflammasome in response to the Gram-negative bacterium Chlamydia muridarum without the need for GBP chr3 to recruit to the pathogen-containing vacuole . How GBP chr3 mediate inflammasome activation in this context is unclear. It is possible that GBP5 might complex with NLRP3 directly to drive activation of the inflammasome (Shenoy et al., 2012) . However, others have found that GBP5, GBP chr3 , or type I IFN signalling are not required for activation of the canonical NLRP3 inflammasome (Henry, Brotcke, Weiss, Thompson, & Monack, 2007; Man et al., 2015; Meunier et al., 2014) . Pilla-Moffett and colleagues reported that the Gbp5 −/− mouse line used to pinpoint a requirement for GBP5 in the activation of the NLRP3 inflammasome (Shenoy et al., 2012) was generated in 129 embryonic stem cells (Pilla-Moffett et al., 2016) . Despite backcrossing to the C57BL/6 background, this Gbp5 −/− mouse line may still carry the 129 alleles of the adjacent Gbp1, Gbp2, Gbp3, and Gbp7 genes (Pilla-Moffett et al., 2016) . The two C57BL/6 Gbp5 −/− mouse lines used to demonstrate a lack of a role for GBP5 (Man et al., 2015; Meunier et al., 2014) were generated in C57BL/6 embryonic stem cells and carry the C57BL/6 alleles of genes encoding GBPs (Pilla-Moffett et al., 2016) . Whether
GBPs can directly interact with NLRP3 to catalyse assembly of the inflammasome warrants further assessment. However, this dilemma also raises intriguing questions surrounding the role of GBPs in the activation of the inflammasome in response to pathogens that are impervious to the localisation of GBPs to the pathogencontaining vacuole.
The antimicrobial functions of GBPs extend to the restriction of viruses, including both ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) viruses . More recent studies have identi- Figure 2d ). The inhibitory effect of GBP5 is dependent on the isoprenylation of GBP5 and its localisation to the Golgi apparatus (Krapp et al., 2016) .
In response to the RNA hepatitis C virus (HCV), human IRGM is localised at the Golgi apparatus and Golgi vesicles carrying replicating HCV, such that IRGM-mediated autophagy processes are exploited by HCV to promote viral replication (Hansen et al., 2017) . These studies highlight the expanding repertoire of membrane-targeting antimicrobial mechanisms used by GBPs and other IFN-inducible proteins against pathogens from different domains of life with very diverse intracellular lifestyles.
| Effects on the pathogen membrane
Emerging evidence has shown that the membrane of the pathogen is directly targeted by GBPs in the cytoplasm following release of the pathogens from the pathogen-containing vacuole. Confocal microscopy techniques revealed that both GBP2 and GBP5 are localised to the surface of the cytosolic bacterium F. novicida and mediate killing of the bacteria in BMDMs (Man et al., 2015; Meunier et al., 2015) .
BMDMs lacking GBP2, GBP5, or GBP chr3 harbour substantially fewer lysed bacteria than did wild-type BMDMs (Man et al., 2015; Meunier et al., 2015) . One of the biological features of GBP-mediated lysis of bacteria is that this host-dependent process liberates concealed bacterial DNA and drives activation of the innate immune DNA sensor absent in melanoma 2 (AIM2) (Man et al., 2015; Meunier et al., 2015) .
Indeed, both GBP2 and GBP5 contribute to the activation of the AIM2 inflammasome, secretion of IL-1β and IL-18, and induction of pyroptosis in macrophages infected with F. novicida (Man et al., 2015; Meunier et al., 2015) . Chemical transfection of synthetic DNA induces activation of the AIM2 inflammasome independently of GBPs and type I IFN signalling (Man et al., 2015; Meunier et al., 2015) , suggesting a specificity of GBPs towards activation of the AIM2 inflammasome induced by F. novicida infection. In addition, macrophages lacking the DNA sensor cyclic guanosine monophosphateadenosine monophosphate synthase and its adaptor stimulator of interferon genes have an impaired ability to activate caspase-1 or mediate the secretion of IL-1β and IL-18 (Jones et al., 2010; Man et al., 2015; Meunier et al., 2015; Storek, Gertsvolf, Ohlson, & Monack, 2015) . The contribution of cyclic guanosine monophosphateadenosine monophosphate synthase and stimulator of interferon genes in this pathway is owing to their ability to induce the expression of type I IFNs, which drive autocrine and/or paracrine activation of the type I signalling cascade and the expression of GBPs.
Ectopic expression of either GBP2 or GBP5 in BMDMs lacking the type I IFN signalling subunit IFNAR1 is unable to "rescue" activation of the AIM2 inflammasome in response to F. novicida infection (Meunier et al., 2015) , suggesting that the function of GBPs must be directed in situ by type I IFN signalling. Further, in the absence of IFN-γ treatment human GBP1 fails to redistribute from the cytoplasm to the Golgi apparatus in HeLa cervical carcinoma cells or primary human foreskin fibroblasts (Modiano et al., 2005) . These studies suggest that GBPs must be guided to the membrane or their desired location by other IFN-inducible factors.
Similar to the observation of bacterial infection, microscopy analysis revealed that GBP2 can directly target the membrane of T. gondii in MEFs (Kravets et al., 2016) . Oligomerisation of GBP2 on the protozoan membrane leads to membrane disruption and permeabilisation and penetration of GBP2 into the cytoplasm of T. gondii (Kravets et al., 2016 ; Figure 2b ). The hypothesis that GBPs mediate lysis of pathogen membrane is further supported by a subsequent study demonstrating a role for GBPs in mediating the localisation and loading of the IRG member IRGB10 to the cell membrane of cytosolic bacteria . Super resolution microscopy and transmission electron microscopy techniques identified endogenous IRGB10 proteins on the bacterial cell membrane within BMDMs that had been infected with F. novicida or Escherichia coli . The presence of GBPs and IRGB10 is associated with rupture of the bacterial cell membrane and reduced bacterial viability, which contributes to either activation of the AIM2 inflammasome in the case of F. novicida infection or activation of the non-canonical NLRP3 inflammasome in the case of E. coli infection ; Figure 2c ). Further, IRGB10 and most IRGs carry two putative transmembrane helices that resemble those found in antimicrobial peptides Martens et al., 2004; Tiwari, Choi, Matsuzawa, Pypaert, & MacMicking, 2009) Howard, 2011) . IRGMs belong to the GMS group and are non-canonical guanine nucleotide dissociation inhibitors, which in most cases act as negative regulators of other IFN-inducible GTPases (Coers, 2013; Hunn et al., 2008) .
Studies have shown that mouse IRGM1 and IRGM3 can bind host lipid droplets but not the membrane of the pathogen-containing vacuole carrying either C. trachomatis or T. gondii (Haldar et al., 2013) . These IRGMs inhibit GTP acquisition and oligomerisation of GBPs and GKS proteins (Haldar et al., 2013; Hunn et al., 2008; Papic, Hunn, Pawlowski, Zerrahn, & Howard, 2008) . GBP1, GBP2, and the GKS proteins IRGA6, IRGB6 and IRGB10 all mislocalise to host lipid droplets in the absence of IRGM1 and IRGM3 (Haldar et al., 2013) . A similar study further observed that in the absence of IRGM1, the GKS proteins IRGA6, IRGB6, IRGB10, and IRGD associate with LAMP1 + lysosomes; in the absence of IRGM3, the GKS protein IRGA6 mislocalises to the endoplasmic reticulum (Maric-Biresev et al., 2016) .
Therefore, IRGMs might bind self-endomembrane to guard against GBPs and GKS proteins (Haldar et al., 2013; MacMicking, 2012) , whereas pathogen-containing vacuoles lacking IRGMs are susceptible to attack (Coers, 2013; Haldar et al., 2013 ). This elegant model conceptually underpins one of the molecular mechanisms that governs the discrimination between self-membrane versus non-self-membrane;
however, how IRGMs avoid migration to the pathogen-containing vacuole is unclear (Figure 2a) .
It is also possible that the membrane of pathogen-containing vacuole displays microbial signatures that attract GBPs. Indeed, loading of GBPs to the pathogen-containing vacuole encasing the Gramnegative vacuolar bacteria L. pneumophila and Yersinia paratuberculosis requires the Dot/Icm secretion system and hypersecretion of the Yersinia type III secretion system, respectively .
The pathogen-containing vacuole encasing L. pneumophila within RAW 264.7 macrophages attracts GBP1, GBP2, and GBP7 . Genetic deletion of the gene encoding the carbohydrate-binding protein galectin-3 impairs the recruitment of GBP1 and GBP2 to the pathogen-containing vacuole occupied by L. pneumophila or Y. paratuberculosis . In addition, Y. pseudotuberculosis translocon proteins and GBPs are recruited to LAMP1 + vacuolar compartments, which induces damage to these LAMP1 + organelles and drives activation of caspase-11 . Therefore, it is possible that virulence factors secreted by bacterial secretion systems are attached to the membrane of the pathogen-containing vacuole, providing a molecular signature that is recognised by galectin-3. Galectin-3 then promotes the recruitment of GBPs to the pathogen-containing vacuole.
The activity of GBPs is also negatively regulated by the Rab regulator RabGDIα (Ohshima et al., 2015) . RabGDIα is capable of binding and sequestering GBP2 in the cytoplasm, retaining it in its GDP-binding state (Ohshima et al., 2015; Figure 2a) . As a result, pathogen-containing vacuoles carrying T. gondii are more frequently targeted by GBP2 and IRGA6 in BMDMs lacking RabGDIα compared to wild-type BMDMs (Ohshima et al., 2015) . The inhibitory function of RabGDIα safe-guards against recognition of self-membrane and potential damage by GBPs and IRGs, but decreases the efficiency of cell-autonomous immunity against parasites (Ohshima et al., 2015) .
Although both IRGMs and RabGDIα are negative regulators of GBPs, they act via distinct mechanisms to contribute to the discrimination of self-membrane and non-self-membrane.
| Additional antimicrobial mechanisms
Alternative mechanisms of antimicrobial activity ascribed to GBPs unrelated to membrane rupture have been identified. GBP1 and GBP7 are able to recruit nicotinamide adenine dinucleotide phosphate (NADPH) oxidase subunits and autophagy-associated factors to the pathogen-containing vacuole carrying Mycobacterium bovis and L. monocytogenes (Kim et al., 2011) . Macrophages treated with a small interfering RNA to reduce the expression of GBP7 have a decreased capacity to target their NADPH oxidase subunits p40 phox and p67 phox to the pathogen-containing vacuole or to generate IFN-γ-induced O 2 − to mediate pathogen killing (Kim et al., 2011) . In addition, GBP1 binds the autophagy factor p62, forming a GBP1-p62 complex that is then transported to the pathogen-containing vacuole of M. bovis (Kim et al., 2011) . p62 can also deliver ubiquitinated pathogen-containing vacuoles to autolysosomes to facilitate killing of Mycobacterium tuberculosis (Alonso, Pethe, Russell, & Purdy, 2007; Ponpuak et al., 2010 ; Figure 2c ).
The pathogen-containing vacuoles of MEFs carrying the bacterium C. trachomatis or the protozoan T. gondii are also targeted by ubiquitin.
In this case, IRGM1, IRGM3, and the E3 ubiquitin ligase TRAF6 mediate the association of ubiquitin to these pathogen-containing vacuoles . The ubiquitin coating further supports p62-dependent delivery of GBP1 and GBP2 to the pathogen-containing vacuoles . Further studies have shown that GBP1 might recruit the IFN-γ-driven E3 ubiquitin ligase TRIM21 to the pathogen-containing vacuole in MEFs infected with T. gondii, where TRIM21 mediates Lys63-linked ubiquitination and restriction of early replication without interfering vacuolar disruption (Foltz et al., 2017) .
The ability of GBPs to recruit additional antimicrobial machineries to the pathogen-containing vacuole adds to the diversity of the molecular mechanisms underpinning cell-autonomous immunity to intracellular pathogens.
| CONCLUSIONS
GBPs and related IFN-inducible GTPases have important roles in cellautonomous immunity and innate immune sensing pathways.
However, there are still many outstanding questions relating to their roles and regulation in targeting host membrane, the membrane of the pathogen-containing vacuole and the membrane of invading pathogens. 
